Simultaneously, tumor-derived lactate induces programmed cell death ligand 1 (PD-L1) expression in infiltrated neutrophils through the MCT1/NF-κB/COX-2 pathway, thus counteracting the efficacy of lenvatinib monotherapy in HCC mouse models [142]. This evidence concerns the gene NFKB1 and neoplasm.